Prevent efficacy task order: chemoprevention of colorectal cancer with olmesartan medoxomil
Ended Awarded Last action
- Contract number
- HHSN26100011
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $521,215
Award facts
- Opportunity
-
- N01CN5500347 Solicitation number
- Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Sep 25, 2015
- Preclinical PREVENT Cancer Program for Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Jan 5, 2015
- Contract value 100% obligated
- $521,214.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$849 | |
| Other Administrative Action | $0 | |
| Original award | $522,064 |
About this award
This is a $521,214.97 Firm Fixed Price delivery order awarded by the National Institutes of Health (NIH) National Cancer Institute to the University of Oklahoma Health Sciences Center to conduct research on the chemoprevention of colorectal cancer with olmesartan medoxomil. The order is part of the NIH's PREVENT Cancer Program, which focuses on preclinical efficacy and intermediate endpoint biomarkers for cancer prevention. The delivery order does not have a set-aside designation. University of Oklahoma is the prime contractor, and there is no information provided about major subcontractors. The NIH is the funding agency for this research effort, which aligns with their mission to support medical research.
Quick answers
Who was awarded contract HHSN26100011?
HHSN26100011 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 15, 2017.
How much is contract HHSN26100011 worth?
The government has obligated $521,215 on HHSN26100011.
Is contract HHSN26100011 an order under another contract?
Yes. HHSN26100011 is a delivery order under HHSN261201500038I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100011 competed?
The extent of competition for HHSN26100011 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award